
DPP-4 Inhibitors Explained: Januvia, Onglyza, and Nesina
Learn how DPP-4 inhibitors like Januvia, Onglyza, and Nesina work to manage type 2 diabetes through the incretin pathway, and why they are a top choice for many.
Deep-research medication guides, drug safety explainers, and cost-saving resources — written for patients and reviewed by pharmacists.

Learn how DPP-4 inhibitors like Januvia, Onglyza, and Nesina work to manage type 2 diabetes through the incretin pathway, and why they are a top choice for many.

Explore the key differences between insulin and GLP-1 agonists like Ozempic for Type 2 Diabetes, including weight effects, safety, and administration.

Explore the key differences between Ozempic and Metformin, including efficacy, weight loss benefits, costs, and which diabetes medication is right for you.

Discover how SGLT2 inhibitors like Jardiance, Farxiga, and Invokana help manage type 2 diabetes by flushing excess sugar through the kidneys.

Metformin is the gold standard for type 2 diabetes, but its side effects can be challenging. Learn how to manage common issues like diarrhea and nausea while staying on track with your health.

This comprehensive guide explores the six major classes of Type 2 Diabetes medications, including their benefits, side effects, and how they help manage blood sugar effectively.

Learn the key differences between GLP-1 medications like Ozempic and Wegovy. This guide explains FDA indications, dosages, and eligibility for diabetes versus chronic weight loss treatments.

Metformin is the gold standard first-line treatment for type 2 diabetes. Learn how it works in the liver and muscles to lower blood sugar safely and effectively.

Discover the essential facts about mixing GLP-1 medications like Ozempic with alcohol. Learn about hypoglycemia risks, pancreatitis concerns, and why your cravings might disappear.

Six distinct GLP-1 drugs are currently FDA-approved in the United States, from the original twice-daily exenatide to the first oral GLP-1 pill. Each has a distinct profile of efficacy, dosing, side effects, and cost.

Ozempic and Wegovy contain the exact same active ingredient — semaglutide — yet they are approved for entirely different purposes, prescribed at different doses, and covered by insurance under different rules.

Without insurance, a monthly supply of semaglutide or tirzepatide costs between $900 and $1,400. Here is a complete guide to manufacturer savings programs, patient assistance, and lower-cost alternatives.